|
|
|
| Webinar: Simplifying ADC Analysis: Real-Time DAR and Concentration Measurement Without Dilution | Unlock faster, safer ADC development with smarter analytics. This Repligen webinar reveals how variable pathlength spectroscopy delivers real-time, accurate DAR and concentration data without dilution. Explore case studies showing reduced variability, minimized handling of potent payloads, and streamlined workflows. Learn how PAT-driven insights enhance process control, accelerate scale-up, and replace traditional UV-Vis methods for more consistent, efficient manufacturing outcomes. Click here to learn more. |
|
|
|
|
By Partha Anbil, MIT Sloan Life Sciences Industry Advisor | FDA's accelerated approval guidance kicked off a rebalancing of new drug approval pathways. Since its 2024 release, the agency has been building on it in a few key areas. | |
|
|
|
|
| Cytotoxicity: How To Provide Operator Safety | Article | By Michael Eder, Single Use Support | ADC payloads active at nanogram concentrations create serious operator safety risks. Here is what manufacturers must get right to protect operators across every stage of production. |
|
|
| A Sustainable Future: Phasing Out Animal Testing | Application Note | MilliporeSigma | Discover a practical roadmap for replacing animal tests with advanced molecular methods, as well as how regulatory updates and innovative technologies are shaping a sustainable future. |
|
|
|
|
FOCUS ON QUALITY/ANALYTICAL METHODS |
|
|
|
| Insights To Sustainable Signaling Devices With Bioluminescent Bacteria | Application Note | By Jéssica Scherer, Mário Luiz Conte da Frota Júnior, Andressa de Moura Silva, et al., INFORS HT | Learn about a protocol for scaling a bioluminescent marine strain that is validated, revealing atypical light kinetics that necessitate an immediate harvesting window for maximum performance. |
|
|
|
|
| How LIMS Supports QC Scaling At Forge Biologics | Case Study | Veeva | Modernizing QC workflows with cloud-based systems eliminates paper inefficiencies, reduces errors, and accelerates reporting. See how streamlined processes improve compliance and enhance visibility. |
|
|
|
|
|
|
|
| Optimized Urine Liquid Biopsy Workflow | Application Note | QIAGEN | Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology. |
|
|
QUALITY/ANALYTICAL METHODS SOLUTIONS |
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|